114 Views

Bain Capital completes Blue Coat acquisition

Bain Capital has closed its previously announced buy of cybersecurity company Blue Coat Systems Inc for about $2.4 billion in cash. The seller was Thoma Bravo LLCGoldman Sachs provided financial advice to Blue Coat on the transaction while Jefferies LLC did likewise for Bain Capital.

772 Views

Apollo agrees to buy Protection 1 and ASG Security

Apollo Global Management LLC has agreed to acquire two security monitoring companies Protection 1 and ASG Security. No financial terms were disclosed for the transaction that is expected be completed in mid-2015. Both companies will merge and operate under the Protection 1 brand. Credit Suisse, Barclays, Deutsche Bank, Jefferies and RBC are providing the financing for the deal. Morgan Stanley and Raymond James are providing financial advice to Protection 1 while Goldman Sachs is doing likewise for ASG Security.

265 Views

Spark Capital Growth leads $275 mln round for Affirm

San Francisco-based financial tech company Affirm has secured $275 million in funding. Spark Capital Growth led round with participation from Jefferies, Andreessen Horowitz, Khosla Ventures and Lightspeed Venture Partners. Affirm was co-founded by Max Levchin, who currently serves as CEO and is a co-founder of PayPal.

266 Views

Francisco Partners to buy ClickSoftware in $438 mln deal

Francisco Partners has agreed to buy ClickSoftware Technologies Ltd. in a deal valued at about $438 million cash. Terms of the deal call for Francisco to pay $12.65 a share cash for each outstanding ClickSoftware share. ClickSoftware provides automated mobile workforce management and optimization products for the service industry. Jefferies LLC provided financial advice to ClickSoftware.

200 Views

PE-owned restaurant chain Bojangles sets IPO pricing terms

Restaurant chain Bojangles Inc will be selling 6.25 million shares of its IPO at between $15 and $17 per share. The company will list the stock on the NASDAQ under the ticker symbol “BOJA.” BofA Merrill Lynch, Wells Fargo Securities and Jefferies are serving as the lead underwriters. Bojangles is a portfolio company of Advent International.

257 Views

Harvest and Cressey recaps VetCor

Harvest Partners LP and Cressey & Company LP has led a recapitalization of VetCor Group Holdings Corp. No financial terms were disclosed. Jefferies LLC provided financial advice to VetCor on the transaction while Golub Capital arranged the senior debt. Headquartered in Hingham, Massachusetts, VetCor is an owner and operator of veterinary hospitals.

VC-backed Cidara Therapeutics rolls out IPO

San Diego-based biotech company Cidara Therapeutics has raised $76.8 million for its IPO after pricing its 4.8 million shares at $16 per share. The stock begins trading Wednesday on the NASDAQ under the ticker symbol “CDTX.” Jefferies LLC and Leerink Partners are the lead underwriters. Cidara’s backers include 5AM Ventures, Aisling Capital, Frazier Healthcare and InterWest Partners.

252 Views

Warburg Pincus and GTCR to recap Sterigenics

Warburg Pincus and GTCR will recapitalize Sterigenics International, a provider of contract sterilization, gamma technologies and medical isotopes. No financial terms were disclosed. The transaction is expected to be completed in the second quarter of this year. Goldman, Sachs & Co. and Jefferies LLC were financial advisors to Sterigenics and GTCR while J.P. Morgan Securities LLC provided additional financial advice to GTCR. Also, JPMorgan will provide debt financing for the recap. Sterigenics is owned by GTCR.

VC-backed Cidara Therapeutics files for IPO

San Diego-based biotech company Cidara Therapeutics has filed for a $69 million IPO, according to an SEC filing. The company plans on trading on the NASDAQ under the ticker symbol “CDTX.” Jefferies and Leerink Partners are listed as lead underwriters. Cidara’s backers include 5AM Ventures, Aisling Capital, Frazier Healthcare and InterWest Partners.

128 Views

VC-backed Flex Pharma files for IPO

According to an SEC filing, Boston-based Flex Pharma, a biotech firm that focuses on treating muscle cramps, has filed for an IPO. Although the number of shares that will be sold as well as the stock’s pricing terms have yet to be set, the document proposes the IPO’s value to be up to $60 million Jefferies and Piper Jaffray are among those named as lead underwriters. Flex Pharma’s backers include Bessemer Venture Partners and Longwood Fund.

 

143 Views

PE-backed AltheaDx files for IPO

AltheaDx, a molecular diagnostics firm, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. AltheaDx plans on listing its stock on the NASDAQ under the ticker symbol “IDGX.” Citigroup and Jefferies are the lead underwriters. AltheaDx’s backers include Telegraph Hill Partners.

Revellers chat on a street before performing at a carnival parade in Havana
491 Views

peHUB Second Opinion

In Second Opinion, Sony cancels the premier of “The Interview,” the U.S. restores diplomatic relations with Cuba and what to do when a VC says no, over and over again.

PE HUB Community

Join the 12518 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget